Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Garassino, I [1 ]
Campagnoli, E. [1 ]
Cavina, R. [1 ]
Soto, Parra H. J. [1 ]
De Vincenzo, F. [1 ]
Zucali, P. A. [1 ]
Salamina, S. [1 ]
Ceresoli, G. L. [1 ]
Santoro, A. [1 ]
机构：
[1] Ist Clin Humanitas, Dept Med Oncol & Hematol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI20 / XI20
页数：1
相关论文
共 50 条
  • [1] Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)
    Campagnoli, E.
    Garassino, I.
    Cavina, R.
    Parra, H. J. Soto
    De Vincenzo, F.
    Zucali, P. A.
    Salamina, S.
    Ceresoli, G. L.
    Santoro, A.
    LUNG CANCER, 2006, 52 : S20 - S20
  • [2] Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)
    Campagnoli, E.
    Garassino, I.
    Cavina, R.
    Parra, H. J. Soto
    De Vincenzo, F.
    Zucali, P. A.
    Salamina, S.
    Ceresoli, G. L.
    Santoro, A.
    PROCEEDINGS OF THE 10TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE, 2006, : 29 - +
  • [3] Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer
    Elisabetta Campagnoli
    Isabella Garassino
    Armando Santoro
    Fabio De Vincenzo
    Paolo Andrea Zucali
    Giovanni Luca Ceresoli
    Fabio Romano Lutman
    Marco Alloisio
    Hector Josè Soto Parra
    Raffaele Cavina
    Investigational New Drugs, 2007, 25 : 559 - 564
  • [4] Phase II trial of alternating intravenous and oral vinorelbine in combination with cisplatin in advanced non-small cell lung cancer
    Campagnoli, Elisabetta
    Garassino, Isabella
    Santoro, Armando
    De Vincenzo, Fabio
    Zucali, Paolo Andrea
    Ceresoli, Giovanni Luca
    Lutman, Fabio Romano
    Alloisio, Marco
    Parra, Hector Jose Soto
    Cavina, Raffaele
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (06) : 559 - 564
  • [5] Gemcitabine, vinorelbine and cisplatin combination chemotherapy in advanced non-small cell lung cancer:: a phase II trial
    Laack, E
    Mende, T
    Dürk, H
    Kneba, M
    Dickgreber, N
    Welte, T
    Müller, T
    Scholtze, J
    Graeven, U
    Jasiewicz, Y
    Edler, L
    Hossfeld, DK
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 654 - 660
  • [6] Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC
    De Lena, M
    Ramlau, R
    Hansen, O
    Lorusso, V
    Wagner, L
    Barni, S
    Cristovao, MM
    Huber, R
    Alberola, V
    Mitrovic, M
    Colin, C
    Gasmi, J
    LUNG CANCER, 2005, 48 (01) : 129 - 135
  • [7] Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer
    Kiyoshi Mori
    Yukari Kamiyama
    Tetsuro Kondo
    Yasuhiko Kano
    Keigo Tominaga
    Cancer Chemotherapy and Pharmacology, 2004, 53 : 129 - 132
  • [8] Phase II study of the combination of vinorelbine and cisplatin in advanced non-small-cell lung cancer
    Mori, K
    Kamiyama, Y
    Kondo, T
    Kano, Y
    Tominaga, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (02) : 129 - 132
  • [9] Phase II trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Antón, A
    Díaz-Fernández, N
    Larriba, JG
    Vadell, C
    Masutti, B
    Montalar, J
    Barneto, I
    Artal, A
    Rosell, R
    LUNG CANCER, 1998, 22 (02) : 139 - 148
  • [10] A randomized phase III trial of tirapazamine (T) in combination with cisplatin (C) and vinorelbine (V) versus cisplatin and vinorelbine in advanced non-small cell lung cancer (NSCLC)
    LeChevalier, T.
    Gatzemeier, U.
    Breton, J. L.
    Cigolari, S.
    Stewart, D.
    Von Pawel, J.
    Firvida, J. L.
    Barcelo, J. R.
    Shen, L.
    Loh, E. Y.
    ANNALS OF ONCOLOGY, 2004, 15 : 165 - 165
12345